Mankind Pharma on Wednesday said its consolidated net profit increased 55 per cent to Rs 460 crore for the third quarter ended December 2023. The company had posted a net profit of Rs 296 crore in the October-December quarter of the last fiscal.
Its revenue from operations rose to Rs 2,607 crore in the period under review from Rs 2,091 crore in the year-ago period, Mankind Pharma said in a statement. Shares of the company ended 2.79 per cent down at Rs 1,999.55 apiece on the BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.